Innate Immunity in Autoimmune Thyroid Disease during Pregnancy

Int J Mol Sci. 2023 Oct 22;24(20):15442. doi: 10.3390/ijms242015442.

Abstract

Autoimmune thyroid disease (AITD) is the most common organ-specific autoimmune disorder clinically presented as Hashimoto thyroiditis (HT) and Graves' disease (GD). The pathogenesis of AITD is caused by an inappropriate immune response related to genetic, non-genetic, and environmental factors. Pregnancy is one of the factors that have a great influence on the function of the thyroid gland because of the increased metabolic demand and the effects of hormones related to pregnancy. During pregnancy, an adaptation of the maternal immune system occurs, especially of the innate immune system engaged in maintaining adaptive immunity in the tolerant state, preventing the rejection of the fetus. Pregnancy-related hormonal changes (estrogen, progesterone, hCG) may modulate the activity of innate immune cells, potentially worsening the course of AITD during pregnancy. This especially applies to NK cells, which are associated with exacerbation of HD and GD. On the other hand, previous thyroid disorders can affect fertility and cause adverse outcomes of pregnancy, such as placental abruption, spontaneous abortion, and premature delivery. Additionally, it can cause fetal growth retardation and may contribute to impaired neuropsychological development of the fetus. Therefore, maintaining the thyroid equilibrium in women of reproductive age and in pregnant women is of the highest importance.

Keywords: NK cells; NKT cells; autoimmune thyroid disease; dendritic cells; neutrophils; pregnancy.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases* / genetics
  • Female
  • Graves Disease* / genetics
  • Hashimoto Disease*
  • Humans
  • Immunity, Innate
  • Placenta / metabolism
  • Pregnancy
  • Thyroid Diseases* / metabolism

Grants and funding

This research received no external funding.